Skip to content
Home/Companies/Pharma/Aphaia Pharma

Aphaia Pharma

Pharma·Switzerland·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Aphaia Pharma?

Aphaia Pharma is currently owned by Bioventure Management through Bioventure Club Deals (2011 vintage), since 2018.

Hand-verified · updated 2026-08-10

Bioventure Management
Investor
Bioventure Management
Bioventure Club Deals · 2011 · Life Sciences VC

Key facts

HQSwitzerland
SectorPharma
StatusActive

More from Bioventure Club Deals

Other portfolio companies in the same fund.

DiaMonTech
DiaMonTech
Active
MedTechGermany· 2025
Repairon
Repairon
Active
BiotechGermany· 2025
Provirex
Provirex
Active
BiotechGermany· 2022
Aptarion Biotech
Aptarion Biotech
Active
BiotechGermany· 2017
Euroimmun
Exited 2017
MedTechGermany· 2013
to
Jennewein Biotechnologie
Exited 2020
BiotechGermany· 2012
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Aphaia Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Aphaia Pharma?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Aphaia Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue